Join us   Log in  

CANCER CASE REPORTS - Volume 3; Issue 1, 2022

Pages: 1-02
Print Article   Download XML  Download PDF

PRIDE Complex Secondary to Cetuximab in Nasopharyngeal Carcinoma

Author: Rohit Kothari, Karthi Kishore, Anuj Bhatnagar

Category: Cancer Research

Full Text:

Clinical Image

A 54-years-old male, case of Nasopharyngeal carcinoma (T1N2M0) was given six monthly doses of Injection Cetuximab. He presented to dermatology clinic with paronychia of left thumb, middle and ring finger, subungual hyperkeratosis (Panel A) and recurrent crops of papulopustular lesions over scalp, face (Panel B), trunk and extremities associated with dryness (white arrow) (Panel C) and itching for last six months. He also complained of excessive hair fall. He was diagnosed as PRIDE complex (Papulopustules and/or paronychia, Regulatory abnormalities of hair-growth, Itching, Dryness) secondary to Cetuximab and treated with oral Doxycycline, topical Clindamycin, tretinoin and emollients. He was in remission at last follow-up after one month.

Conflict of Interest: None for all authors

Data Availability Statement: The data that support the findings of this study are available from the corresponding author upon reasonable request.

Acknowledgement: The patient in this manuscript has given written informed consent to the publication of his case details and photographs.

Author Contribution Statement: The manuscript has been read and approved by all the authors and each author believes that the manuscript represents honest work.